Home / Cardiovascular system / Trandolapril
ATC C09AA10 · Ace Inhibitors, Plain
Trandolapril shortage
As of 2 Nov 2026, Trandolapril has a reported shortage in 4 of the 15 countries we track (Canada, France, Czechia, Australia), covering 14 products from 4 companies.
Countries4/15
Products14packs or presentations
Companies42 listed
Short since4 Jul 20242.3 years ago
Earliest return20 Nov 2026company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada7 products shortGermanyNo reported shortageFrance1 product shortItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechia2 products shortNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustralia4 products short
Timeline
CanadaFranceCzechiaAustralia
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group C09AA · Ace Inhibitors, PlainAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MAVIK (100BT) | BGP PHARMA ULC | 1 Jun 2026 | 5 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TRANDOLAPRIL (100) | PRO DOC LIMITEE | 30 Jun 2026 | 15 Jan 2027 | Distribution or logistics Delay in shipping of the drug |
| CA | SANDOZ TRANDOLAPRIL (100HGC) | SANDOZ CANADA INCORPORATED | 6 Jul 2026 | 5 Mar 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | SANDOZ TRANDOLAPRIL (100HGC) | SANDOZ CANADA INCORPORATED | 13 Jul 2026 | 5 Mar 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | SANDOZ TRANDOLAPRIL (100HGC) | SANDOZ CANADA INCORPORATED | 13 Jul 2026 | 5 Mar 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MAVIK (100 CA) | BGP PHARMA ULC | 23 Sep 2026 | 5 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | SANDOZ TRANDOLAPRIL (100HGC) | SANDOZ CANADA INCORPORATED | 13 Oct 2026 | 5 Mar 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| FR | Trandolapril 2 mg et 4 mg limited | 4 Jul 2024 | not given | Not stated | |
| CZ | GOPTEN 4MG 4MG CPS DUR 56 | VIATRIS HEALTHCARE LIMITED, Dublin | 15 Oct 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | GOPTEN 2MG 2MG CPS DUR 98 anticipated | VIATRIS HEALTHCARE LIMITED, Dublin | 15 Nov 2026 | 31 Jan 2027 | Manufacturing problem Výrobní důvody |
| AU | DOLAPRIL 4 trandolapril 4 mg capsule blister pack | 13 Aug 2026 | 19 Mar 2027 | Not stated | |
| AU | TRANDOLAPRIL VIATRIS trandolapril 4 mg capsule blister pack | 9 Sep 2026 | 18 Dec 2026 | Not stated | |
| AU | GOPTEN trandolapril 2 mg capsule blister pack limited | 20 Oct 2026 | 20 Nov 2026 | Not stated | |
| AU | GOPTEN trandolapril 4 mg capsule blister pack anticipated | 9 Nov 2026 | 18 Dec 2026 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.